Quality of TCR signaling determined by differential affinities of enhancers for the composite BATF-IRF4 transcription factor complex

Nature Immunology

Volumn 18, Issue 5, 2017, Pages 563-572

  Iwata, Arifumi ^a   Durai, Vivek ^a   Tussiwand, Roxane ^b   Briseño, Carlos G ^a   Wu, Xiaodi ^a   Grajales Reyes, Gary E ^a   Egawa, Takeshi ^a   Murphy, Theresa L ^a   Murphy, Kenneth M ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CHEMOKINE RECEPTOR CCR4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR MAF; BATF PROTEIN, MOUSE; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; LYMPHOCYTE ANTIGEN RECEPTOR; MULTIPROTEIN COMPLEX; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; ENHANCER REGION; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TH2 CELL; 129 MOUSE; ANIMAL; AUTOIMMUNITY; BAGG ALBINO MOUSE; GENETIC PREDISPOSITION; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; AUTOIMMUNITY; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CTLA-4 ANTIGEN; ENHANCER ELEMENTS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON REGULATORY FACTORS; MICE; MICE, 129 STRAIN; MICE, INBRED BALB C; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 85016123436     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3714     Document Type: Article

References (52)

1. Li, M.O. &Rudensky, A.Y. T cell receptor signalling in the control of regulatory T cell differentiation and function. Nat. Rev. Immunol. 16, 220-233 (2016).
2. Tubo, N.J. &Jenkins, M.K. TCR signal quantity and quality in CD4+ T cell differentiation. Trends Immunol. 35, 591-596 (2014).
3. Mayya, V. &Dustin, M.L. What scales the T cell response? Trends Immunol. 37, 513-522 (2016).
4. Constant, S. et al. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 182, 1591-1596 (1995).
5. Hosken, N.A. et al. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 182, 1579-1584 (1995).
6. Tubo, N.J. et al. Single naive CD4+ T cells from a diverse repertoire produce different effector cell types during infection. Cell 153, 785-796 (2013).
7. Saraiva, M. et al. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31, 209-219 (2009).
8. Man, K. et al. The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat. Immunol. 14, 1155-1165 (2013).
9. Nayar, R. et al. Graded levels of IRF4 regulate CD8+ T cell differentiation and expansion, but not attrition, in response to acute virus infection. J. Immunol. 192, 5881-5893 (2014).
10. Yao, S. et al. Interferon regulatory factor 4 sustains CD8+ T cell expansion and effector differentiation. Immunity 39, 833-845 (2013).
11. Huber, M. &Lohoff, M. IRF4 at the crossroads of effector T-cell fate decision. Eur. J. Immunol. 44, 1886-1895 (2014).
12. De Silva, N.S. et al. The diverse roles of IRF4 in late germinal center B-cell differentiation. Immunol. Rev. 247, 73-92 (2012).
13. Tussiwand, R. et al. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 490, 502-507 (2012).
14. Glasmacher, E. et al. A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science 338, 975-980 (2012).
15. Li, P. et al. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 490, 543-546 (2012).
16. Ciofani, M. et al. A validated regulatory network for th17 cell specification. Cell 151, 289-303 (2012).
17. Murphy, T.L., Tussiwand, R. &Murphy, K.M. Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks. Nat. Rev. Immunol. 13, 499-509 (2013).
18. Ochiai, K. et al. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity 38, 918-929 (2013).
19. Jabeen, R. et al. Th9 cell development requires a BATF-regulated transcriptional network. J. Clin. Invest. 123, 4641-4653 (2013).
20. Kurachi, M. et al. The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells. Nat. Immunol. 15, 373-383 (2014).
21. Ise, W. et al. The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat. Immunol. 12, 536-543 (2011).
22. Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8α+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097-1100 (2008).
23. Yosef, N. et al. Dynamic regulatory network controlling TH17 cell differentiation. Nature 496, 461-468 (2013).
24. Betz, B.C. et al. Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. J. Exp. Med. 207, 933-942 (2010).
25. Schraml, B.U. et al. The AP-1 transcription factor Batf controls TH17 differentiation. Nature 460, 405-409 (2009).
26. Gregersen, P.K. et al. REL, encoding a member of the NF-&kapp;aB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat. Genet. 41, 820-823 (2009).
27. Chung, S.A. et al. Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis. Arthritis Rheum. 64, 3463-3471 (2012).
28. Lohoff, M. et al. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl. Acad. Sci. USA 99, 11808-11812 (2002).
29. Rhee, H.S. &Pugh, B.F. Comprehensive genome-wide protein-DNA interactions detected at single-nucleotide resolution. Cell 147, 1408-1419 (2011).
30. McInnes, I.B. &Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205-2219 (2011).
31. Chen, M. &Kallenberg, C.G. ANCA-associated vasculitides-advances in pathogenesis and treatment. Nat. Rev. Rheumatol. 6, 653-664 (2010).
32. Grajales-Reyes, G.E. et al. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α+ conventional DC clonogenic progenitor. Nat. Immunol. 16, 708-717 (2015).
33. Nayar, R. et al. IRF4 regulates the ratio of T-Bet to Eomesodermin in CD8+ T cells responding to persistent LCMV infection. PLoS One 10, e0144826-(2015).
34. Allison, K.A. et al. Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells. eLife. 5, e10134 (2016).
35. Papatsenko, D. &Levine, M. Quantitative analysis of binding motifs mediating diverse spatial readouts of the Dorsal gradient in the Drosophila embryo. Proc. Natl. Acad. Sci. USA 102, 4966-4971 (2005).
36. Ashe, H.L. &Briscoe, J. The interpretation of morphogen gradients. Development 133, 385-394 (2006).
37. Levo, M. &Segal, E. In pursuit of design principles of regulatory sequences. Nat. Rev. Genet. 15, 453-468 (2014).
38. Kuehn, H.S. et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 345, 1623-1627 (2014).
39. Romo-Tena, J., Gomez-Martin, D. &Alcocer-Varela, J. CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance. Autoimmun. Rev. 12, 1171-1176 (2013).
40. Lenardo, M., Lo, B. &Lucas, C.L. Genomics of immune diseases and new therapies. Annu. Rev. Immunol. 34, 121-149 (2016).
41. Dignam, J.D., Lebovitz, R.M. &Roeder, R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489 (1983).
42. Szabo, S.J. et al. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc. Mol. Cell. Biol. 13, 4793-4805 (1993).
43. Darrah, P.A. et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13, 843-850 (2007).
44. Shooshtari, P. et al. Correlation analysis of intracellular and secreted cytokines via the generalized integrated mean fluorescence intensity. Cytometry A 77, 873-880 (2010).
45. Ritchie, M.E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
46. Langmead, B. et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
47. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
48. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
49. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).
50. Quinlan, A.R. &Hall, I.M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).
51. Serandour, A.A. et al. Development of an Illumina-based ChIP-exonuclease method provides insight into FoxA1-DNA binding properties. Genome Biol. 14, R147 (2013).
52. Storey, J.D. &Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440-9445 (2003).